This invention relates to proteins or peptides that elicit T cell mediated immunity, and to cancer vaccines and compositions for anti-cancer treatment comprising such proteins or peptide fragments. This invention also relates to pharmaceutical compositions comprising the proteins or peptides and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in a mammal. More specifically, a telomerase protein or peptide for use in a method of treatment or prophylaxis of cancer is provided. In a preferred embodiment, the method comprises generating a T cell response against telomerase.

 
Web www.patentalert.com

< Anti-mesothelin antibodies having high binding affinity

< Water-in-oil emulsions with ethylene oxide groups, compositions, and methods

> B7-DC, Dendritic cell co-stimulatory molecules

> Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies

~ 00253